Stelo is an over-the-counter glucose biosensor. This page explains which package, shipment, billing and commitment details to check when comparing an offer. Confirm the currently available purchase options and terms with Dexcom; the sensor’s FDA indication is separate from a particular purchase plan.
Stelo supports up to 15-day wear with its own app and OTC indication. Check the current plan for sensor quantities and delivery terms. Dexcom Stelo is an over-the-counter device for people aged 2 years and older who do not use insulin, with caregiver supervision below 18. It is not intended for problematic hypoglycemia or dialysis and has no clinical high/low alarms. Platform enrollment may have narrower eligibility. Ask your plan administrator whether the specific purchase qualifies for HSA/FSA reimbursement. FDA clearance and OTC availability alone do not establish eligibility.
GlucoseForge may earn a commission from links on this page.
Medical Disclaimer: This content is for informational purposes only. Stelo is not for people on insulin or at risk of severe hypoglycemia. Always consult your healthcare provider.
| Offer detail | What to check | Scope |
|---|---|---|
| Sensor quantity | Confirm the number of sensors in the selected offer | Up to 15-day wear per sensor under its instructions |
| Shipment and billing | Check current shipment dates, billing periods and renewal terms | Do not infer continuous coverage from a package name |
| Commitment | Check pause, cancellation and refund terms before purchase | This page does not establish a no-commitment or cancellation entitlement |
Stelo supports up to 15-day wear per sensor under its instructions. Check Dexcom’s selected offer for the sensor quantity, shipment schedule, billing period and pause or cancellation terms. Maximum labeled wear does not establish continuous coverage or a particular plan entitlement.
For a closer look at the OTC alternative, see our Stelo vs Abbott Lingo comparison. To weigh the cost side by side, use the CGM cost calculator.
Ask your plan administrator whether the specific purchase qualifies for HSA/FSA reimbursement. FDA clearance and OTC availability alone do not establish eligibility. Coverage depends on the plan. Insulin treatment may meet one Medicare condition, but all applicable requirements still apply. Read the coverage guide →
| Device | Sensor wear | Published MARD |
|---|---|---|
| Abbott Lingo | 14 days | 8.1–10.7% (by glucose range; FDA K233655 decision summary) |
| Dexcom Stelo | Up to 15 days | 7.3–9.1% (by wear period; FDA K234070) |
Compare current app features, intended uses and study-specific figures without treating separate MARD studies as an accuracy ranking.
Enter your own prices to compare calculated cost for your monitoring period.
GlucoseForge CGM Cost Calculator →Medical source review, 25 October 2026. Sources apply to their named models, populations and endpoints: Stelo FDA K260935; Original Libre 3, Alva 2023; Libre 3 Plus manufacturer kit, page 5; Guardian 4 FDA, table 17; Eversense E3 US IFU; Eversense 365 ENHANCE; Lingo FDA K233655; Abbott Lingo Count; Medicare LCD L33822; Maryland PT63-26.